BACKGROUND: In Mexican Americans, the IRS1 G972R polymorphism (rs1801278) has been associated to such a marked reduction in glomerular filtration rate (GFR) (i.e. β = -8.3 mL/min/1.73 m(2)) to be considered a major determinant of kidney function. METHODS: This was a cross-sectional study to investigate whether a similarly strong effect can also be observed among individuals of European ancestry. We investigated a total of 3973 White patients with type 2 diabetes. Standardized serum creatinine was measured by the modified kinetic Jaffè reaction and estimated GFR (eGFR) calculated by the modification diet renal disease (MDRD) formula; rs1801278 was genotyped by TaqMan assay. RESULTS: No significant association was observed, with R972 carriers showing only a modestly, not significant, lower eGFR level as compared with other subjects (β = -1.82 mL/min/1.73 m(2), P = 0.086). CONCLUSIONS: Our data indicate that IRS1 G972R is not a strong determinant of GFR in diabetic patients of European ancestry as in Mexican Americans. Since we had 100% power to detect the previously reported association, the risk our finding is a false negative one is minimal.
BACKGROUND: In Mexican Americans, the IRS1 G972R polymorphism (rs1801278) has been associated to such a marked reduction in glomerular filtration rate (GFR) (i.e. β = -8.3 mL/min/1.73 m(2)) to be considered a major determinant of kidney function. METHODS: This was a cross-sectional study to investigate whether a similarly strong effect can also be observed among individuals of European ancestry. We investigated a total of 3973 White patients with type 2 diabetes. Standardized serum creatinine was measured by the modified kinetic Jaffè reaction and estimated GFR (eGFR) calculated by the modification diet renal disease (MDRD) formula; rs1801278 was genotyped by TaqMan assay. RESULTS: No significant association was observed, with R972 carriers showing only a modestly, not significant, lower eGFR level as compared with other subjects (β = -1.82 mL/min/1.73 m(2), P = 0.086). CONCLUSIONS: Our data indicate that IRS1 G972R is not a strong determinant of GFR in diabeticpatients of European ancestry as in Mexican Americans. Since we had 100% power to detect the previously reported association, the risk our finding is a false negative one is minimal.
Authors: Luis H Canani; Daniel P K Ng; Adam Smiles; John J Rogus; James H Warram; Andrzej S Krolewski Journal: Diabetes Date: 2002-04 Impact factor: 9.461
Authors: S De Cosmo; A Argiolas; G Miscio; S Thomas; G P Piras; R Trevisan; P C Perin; S Bacci; L Zucaro; M Margaglione; L Frittitta; A Pizzuti; V Tassi; G C Viberti; V Trischitta Journal: Diabetes Date: 2000-03 Impact factor: 9.461
Authors: Jing Chen; Paul Muntner; L Lee Hamm; Vivian Fonseca; Vecihi Batuman; Paul K Whelton; Jiang He Journal: J Am Soc Nephrol Date: 2003-02 Impact factor: 10.121
Authors: Carl D Langefeld; Stephanie R Beck; Donald W Bowden; Stephen S Rich; Lynne E Wagenknecht; Barry I Freedman Journal: Am J Kidney Dis Date: 2004-05 Impact factor: 8.860
Authors: Sobha Puppala; Rector Arya; Farook Thameem; Nedal H Arar; Kusum Bhandari; Donna M Lehman; Jennifer Schneider; Sharon Fowler; Vidya S Farook; Vincent P Diego; Laura Almasy; John Blangero; Michael P Stern; Ravindranath Duggirala; Hanna E Abboud Journal: Diabetes Date: 2007-08-13 Impact factor: 9.461
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391